[Temporary Announcement] Weiyuan Likang: Announcement of Resolutions of the 18th Meeting of the First Board of Directors

Announcement number: 2026-006

Securities code: 874109 Securities abbreviation: Weiyuan Likang Sponsoring broker: Zhongtai Securities

Beijing Weiyuan Likang Biotechnology Co., Ltd.

Announcement of Resolutions of the 18th Meeting of the First Board of Directors

The company and all members of the board of directors guarantee that the contents of the announcement are true, accurate and complete, and that there are no false records, misleading statements or major omissions, and bear individual and joint legal liability for the authenticity, accuracy and completeness of the contents.

1. Meeting convening and attendance

(1) Meeting status

1. Meeting time: February 2, 2026

2. Meeting method: √On-site meeting □Electronic communication meeting

3. Meeting place: Beijing Weiyuan Likang Biotechnology Co., Ltd. conference room

4. Time and method of issuing board meeting notice: in writing on January 21, 2026 5. Meeting host: Chairman Mr. Li Xiaopeng

5. Personnel attending the meeting: directors, supervisors, senior managers

6. Explanation on the legality and compliance of the convening situation:

The number of participants, convening, convening procedures, and discussion content of this meeting are all in compliance with relevant laws, regulations and the Articles of Association.

(2) Meeting attendance

The meeting should be attended by 5 directors, and 5 directors should be present and authorized to attend.

2. Proposal review status

(1) Consideration and approval of the "Proposal on the Use of Raised Funds to Replace Pre-invested Self-raised Funds"

1. Contents of the motion:

For details, please refer to the company’s designated information in the National Equities Exchange and Quotations on February 2, 2026.

Announcement number: 2026-006

The "Announcement on Beijing Weiyuan Likang Biotechnology Co., Ltd.'s use of raised funds to replace pre-invested self-raised funds" disclosed on the disclosure platform (Announcement No.: 2026-007).

2. Avoidance of voting:

This proposal does not involve related transactions and there is no need to avoid voting.

3. Voting results for the motion: 5 votes in favor; 0 votes against; 0 abstentions.

4. Submit the voting status of the shareholders’ meeting:

This proposal does not need to be submitted to the shareholders' meeting for review.

3. Documents for reference

"Resolution of the 18th Meeting of the First Board of Directors of Beijing Weiyuan Likang Biotechnology Co., Ltd."

Board of Directors of Beijing Weiyuan Likang Biotechnology Co., Ltd.

February 3, 2026